205 episodes

We believe in the educational merits of Free Open Access Medical education (FOAM), which includes podcasts, blogs, articles on PubMed Central, conferences streamed for free and more. As a result, we would like to encourage others to move beyond quoting podcasts and into the realm of tying “cutting edge” FOAM to the core content. We’ll provide some review and references for listeners to go read. Why, indeed, should we FOAM it alone when FOAM can inspire us to go, read, think, and be excellent?

FOAMcast - Emergency Medicine Core Content FOAMcast

    • Medicine
    • 5.0 • 24 Ratings

We believe in the educational merits of Free Open Access Medical education (FOAM), which includes podcasts, blogs, articles on PubMed Central, conferences streamed for free and more. As a result, we would like to encourage others to move beyond quoting podcasts and into the realm of tying “cutting edge” FOAM to the core content. We’ll provide some review and references for listeners to go read. Why, indeed, should we FOAM it alone when FOAM can inspire us to go, read, think, and be excellent?

    COVIDcast - Tocilizumab

    COVIDcast - Tocilizumab

    We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear*
    Monoclonal antibodies have received significant attention over the past month and we previously podcasted on antibodies that target SARS-CoV-2. In this episode, we review several recent studies on a different "mab", tocilizumab,  which targets inflammation mediated by interleukin-6 that is overly ramped up. 
    We review:
    Stone et al  ( RCT)
    Hermine et al (RCT)
    Salvarani et al. (RCT)
    STOP-COVID (observational)
    Show notes (references/graphics): FOAMcast.org
    Thanks for listening,
    Lauren Westafer and Jeremy Faust

    • 20 min
    COVIDcast: Monoclonal Antibodies

    COVIDcast: Monoclonal Antibodies

    We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear*
    Monoclonal antibodies have received significant attention over the past couple of weeks. In this episode, we review what we know, as of October 9, 2020, about monoclonal antibodies as a therapy for COVID-19. 
    Show notes (references/graphics): FOAMcast.org
    Thanks for listening,
    Lauren Westafer and Jeremy Faust

    • 17 min
    COVIDcast: High Flow Nasal Cannula and Health Care Worker Infections

    COVIDcast: High Flow Nasal Cannula and Health Care Worker Infections

    We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear*
    We review a retrospective evaluation of COVID-19 infections in employees after a protocol that increased the use of high flow nasal cannula (Westafer et al)
    Show notes (references/graphics): FOAMcast.org
    Thanks for listening,
    Lauren Westafer and Jeremy Faust

    • 10 min
    Lit Update: PE Risk Stratification Tool Performance (PESI, sPESI, BOVA)

    Lit Update: PE Risk Stratification Tool Performance (PESI, sPESI, BOVA)

    We spoonfeed you a new article on risk stratification of pulmonary embolism (with critical appraisal pearls!)
    In this episode, we review a new trial by Barnes et al on antacids versus antacids with lidocaine for epigastric pain and dyspepsia
    Show notes and references at FOAMcast.org
    Thanks for listening,
    Lauren Westafer and Jeremy Faust

    • 11 min
    COVIDcast: Steroids in COVID-19

    COVIDcast: Steroids in COVID-19

    We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear*
    We review a new meta-analysis from the WHO REACT group of steroids in critically ill patients with COVID-19 and 3 new randomized trials of steroids in COVID-19 published in JAMA on September 2:
    REMAP-CAP COVID-19  CoDEX CAPE Covid Show notes (references/graphics): FOAMcast.org
    Thanks for listening,
    Lauren Westafer and Jeremy Faust

    • 15 min
    COVIDcast: Convalescent Plasma Update

    COVIDcast: Convalescent Plasma Update

    We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear*
    We review the evidence, to date, on convalescent plasma for the treatment of COVID-19. This includes 3 randomized trials, as well the US experience with >35,000 patients treated with convalescent plasma, a noncontrolled study by Joyner et al [pre-print].
    Show notes (references/graphics): FOAMcast.org
    Thanks for listening,
    Lauren Westafer and Jeremy Faust

    • 14 min

Customer Reviews

5.0 out of 5
24 Ratings

24 Ratings

DR R W ,

Useful

Interesting, well presented and mostly relevant even in a difficult health care system - a difficult thing to achieve. Thank You

Doctor-woman ,

Thank you

Thank you editors for creating such a hepful podcasts series, I love it

Jakethemedic ,

Excellent podcast, excellent people

Having had the pleasure of singing karaoke with one half of FOAMcast at RCEM 2016, I have to say that they seem as intelligent and interesting as they seem on the podcast. A brilliant, very up to date podcast, with emphasis on spaced repetition!

Top Podcasts In Medicine

Listeners Also Subscribed To